MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $165 | +139.1% | 40,034 | +239.3% | 0.00% | 0.0% |
| Q4 2022 | $69 | -100.0% | 11,799 | -92.5% | 0.00% | -92.9% |
| Q3 2022 | $1,064,000 | +801.7% | 157,411 | +516.6% | 0.01% | +1300.0% |
| Q2 2022 | $118,000 | -89.3% | 25,529 | -90.8% | 0.00% | -92.9% |
| Q1 2022 | $1,106,000 | +485.2% | 277,089 | +811.1% | 0.01% | +600.0% |
| Q4 2021 | $189,000 | -34.1% | 30,411 | +43.8% | 0.00% | -33.3% |
| Q2 2021 | $287,000 | -67.0% | 21,147 | -35.3% | 0.00% | -62.5% |
| Q4 2020 | $870,000 | +3.9% | 32,704 | -27.3% | 0.01% | -52.9% |
| Q3 2020 | $837,000 | +191.6% | 44,958 | -17.5% | 0.02% | -19.0% |
| Q1 2019 | $287,000 | – | 54,498 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |